Screener
Elanco Animal Health Inc. ELAN Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Elanco Animal Health Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Elanco Animal Health Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001739104-26-000043
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net income | $111 | $78 |
| Adjustments to reconcile net income to cash flows from operating activities: | ||
| Depreciation and amortization | 343 | 330 |
| Stock-based compensation expense | 41 | 35 |
| Sold portion of royalty revenue | (18) | (4) |
| Interest on liability for sale of future revenue | 29 | 7 |
| Changes in operating assets and liabilities, net of acquisitions and divestitures | (239) | (185) |
| Other non-cash operating activities, net | 23 | (28) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Elanco Animal Health Inc.'s stock-based comp?
- Elanco Animal Health Inc. (ELAN) reported stock-based comp of $20M in Q2 2026.
- How has Elanco Animal Health Inc.'s stock-based comp changed year-over-year?
- Elanco Animal Health Inc.'s stock-based comp decreased by 0.0% year-over-year, from $20M to $20M.
- What is the long-term trend for Elanco Animal Health Inc.'s stock-based comp?
- Over 4 years (2021 to 2025), Elanco Animal Health Inc.'s stock-based comp has grown at a 0.7% compound annual growth rate (CAGR), from $66M to $68M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Elanco Animal Health Inc.'s stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude